Nutrien Agrees to Divest 50% Stake in Profertil for $600 Million
Werte in diesem Artikel
Nutrien Ltd. NTR has agreed to sell its 50% equity interest in Profertil S.A., an Argentina-based nitrogen producer. The stake will be jointly acquired by Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda. Nutrien’s 50% stake is expected to be priced at around $600 million on a pre-tax basis.The transaction is expected to help Nutrien focus more effectively on its core competencies, assets and geographies. The initiative is aligned with Nutrien’s long-term strategy as the proceeds from this divestiture will be targeted toward growth investments, share repurchases and debt reduction.The transaction is expected to close before the end of 2025, subject to customary closing conditions. As per the agreement, the other 50% equity holder has a 90-day right of first refusal to acquire Nutrien’s stake on the same terms and conditions.According to the proportion of Nutrien’s holding, the Nitrogen operating segment earnings from Profertil recorded approximately $60 million over the previous four quarters. The sale of Profertil will further enhance Nutrien’s quality of earnings and cash flow.NTR stock has gained 32.3% over the past year compared with the industry’s 26.9% rise.Image Source: Zacks Investment ResearchNTR’s Zacks Rank & Key PicksNTR currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are The Mosaic Company MOS, Carpenter Technology Corporation CRS and Avino Silver & Gold Mines Ltd. ASM. MOS and CRS sport a Zacks Rank #1 (Strong Buy) each at present, while ASM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for MOS’ 2025 earnings is pegged at $3.17 per share, indicating a rise of 60.10% from year-ago levels. The company’s earnings beat the consensus estimate in one of the trailing four quarters while missing it in the rest. Its shares have gained 36.7% in the past year.The Zacks Consensus Estimate for CRS’ current fiscal-year earnings is pegged at $9.51 per share, indicating a 27.14% year-over-year increase.Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.38%. CRS’shares have surged 86.9% in the past year.The Zacks Consensus Estimate for ASM’s current-year earnings is pegged at 11 cents per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 141.67%. ASM shares have jumped 355.3% in the past year. Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Carpenter Technology Corporation (CRS): Free Stock Analysis Report The Mosaic Company (MOS): Free Stock Analysis Report Avino Silver (ASM): Free Stock Analysis Report Nutrien Ltd. (NTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Nutrien (Ex Potash Agrium)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Nutrien (Ex Potash Agrium)
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Nutrien (Ex Potash Agrium)
Analysen zu Nutrien (Ex Potash Agrium)
Datum | Rating | Analyst | |
---|---|---|---|
08.09.2025 | Nutrien (Ex Potash Agrium) Hold | Jefferies & Company Inc. | |
08.09.2025 | Nutrien (Ex Potash Agrium) Outperform | RBC Capital Markets | |
11.08.2025 | Nutrien (Ex Potash Agrium) Outperform | RBC Capital Markets | |
11.08.2025 | Nutrien (Ex Potash Agrium) Overweight | JP Morgan Chase & Co. | |
08.08.2025 | Nutrien (Ex Potash Agrium) Hold | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
08.09.2025 | Nutrien (Ex Potash Agrium) Outperform | RBC Capital Markets | |
11.08.2025 | Nutrien (Ex Potash Agrium) Outperform | RBC Capital Markets | |
11.08.2025 | Nutrien (Ex Potash Agrium) Overweight | JP Morgan Chase & Co. | |
14.07.2025 | Nutrien (Ex Potash Agrium) Outperform | RBC Capital Markets | |
09.05.2025 | Nutrien (Ex Potash Agrium) Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
08.09.2025 | Nutrien (Ex Potash Agrium) Hold | Jefferies & Company Inc. | |
08.08.2025 | Nutrien (Ex Potash Agrium) Hold | Jefferies & Company Inc. | |
07.08.2025 | Nutrien (Ex Potash Agrium) Neutral | UBS AG | |
07.04.2025 | Nutrien (Ex Potash Agrium) Neutral | UBS AG | |
03.03.2025 | Nutrien (Ex Potash Agrium) Neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
18.11.2024 | Nutrien (Ex Potash Agrium) Underweight | JP Morgan Chase & Co. | |
09.08.2024 | Nutrien (Ex Potash Agrium) Underweight | JP Morgan Chase & Co. | |
23.02.2024 | Nutrien (Ex Potash Agrium) Underweight | JP Morgan Chase & Co. | |
07.07.2023 | Nutrien (Ex Potash Agrium) Underperform | Credit Suisse Group | |
16.02.2023 | Nutrien (Ex Potash Agrium) Underperform | Credit Suisse Group |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nutrien (Ex Potash Agrium) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen